Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-03

Clinical Trial Update: High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

View source ↗

Summary

Clinical trial update on high-dose, interval Vitamin D supplementation for patients with inflammatory bowel disease on biologic therapy; recruiting participants…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Inflammatory Bowel Disease, Crohn Disease | Status: RECRUITING